Etripamil

etripamil · Milestone Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Etripamil, covering 2023-04-24 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 [Phase 3]